What's new

Human medicines European public assessment report (EPAR): Artesunate Amivas, artesunate, Date of authorisation: 22/11/2021, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR): Artesunate Amivas, artesunate, Date of authorisation: 22/11/2021, Revision: 6, Status: Authorised

May 20, 2025 - 13:35
 0
Human medicines European public assessment report (EPAR): Artesunate Amivas, artesunate, Date of authorisation: 22/11/2021, Revision: 6, Status: Authorised
Human medicines European public assessment report (EPAR): Artesunate Amivas, artesunate, Date of authorisation: 22/11/2021, Revision: 6, Status: Authorised
Read More

Tags:

Previous Article

STAT+: Tourmaline drug cuts inflammation tied to heart disease

Next Article

Human medicines European public assessment report (EPAR): Eltrombopag Accord, el...

Related Posts

Human medicines European public assessment report (EPAR): Zavicefta, ceftazidime,avibactam, Date of authorisation: 23/06/2016, Revision: 19, Status: Authorised

Human medicines European public assessment report (EPAR...

May 20, 2025  0

Human medicines European public assessment report (EPAR): Clopidogrel Krka, clopidogrel, Date of authorisation: 23/09/2009, Revision: 20, Status: Authorised

Human medicines European public assessment report (EPAR...

May 14, 2025  0

Human medicines European public assessment report (EPAR): Levetiracetam Hospira, levetiracetam, Date of authorisation: 07/01/2014, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR...

May 12, 2025  0